The Journal of Neuroscience, November 29, 2006, 26(48):12408-12414; doi:10.1523/JNEUROSCI.3372-06.2006
Previous Article | Next Article 
Neurobiology of Disease
Accelerated Accumulation of Misfolded Prion Protein and Spongiform Degeneration in a Drosophila Model of GerstmannSträusslerScheinker Syndrome
Brendan A. Gavin,1
Maria J. Dolph,1
Nathan R. Deleault,2
James C. Geoghegan,2
Vikram Khurana,3
Mel B. Feany,3
Patrick J. Dolph,1 and
Surachai Supattapone2
1Department of Biology, Dartmouth College, Hanover, New Hampshire 03755, 2Department of Biochemistry, Dartmouth Medical School, Hanover, New Hampshire 03755, and 3Department of Pathology, Division of Neuropathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115
Correspondence should be addressed to either of the following: Surachai Supattapone, Department of Biochemistry, Dartmouth Medical School, 7200 Vail Building, Hanover, NH 03755, Email: supattapone{at}Dartmouth.edu; or Patrick J. Dolph, Department of Biology, Dartmouth College, Hanover, NH 03755, Email: partick.j.dolph{at}dartmoth.edu
Prion diseases are CNS disorders that can occur in sporadic, infectious, and inherited forms. Although all forms of prion disease are associated with the accumulation of pathogenic conformers of the prion protein, collectively termed PrPSc, the mechanisms by which PrPSc molecules form and cause neuronal degeneration are unknown. Using the bipartite galactosidase-4upstream activating sequence expression system, we generated transgenic Drosophila melanogaster heterologously expressing either wild-type (WT) or mutant, disease-associated (P101L) mouse PrP molecules in cholinergic neurons. Transgenic flies expressing neuronal P101L PrP molecules exhibited severe locomotor dysfunction and premature death as larvae and adults. These striking clinical abnormalities were accompanied by age-dependent accumulation of misfolded PrP molecules, intracellular PrP aggregates, and neuronal vacuoles. In contrast, transgenic flies expressing comparable levels of WT PrP displayed no clinical, pathological, or biochemical abnormalities. These results indicate that transgenic Drosophila expressing neuronal P101L PrP specifically exhibit several hallmark features of human GerstmannSträusslerScheinker (GSS) syndrome. Because the rates of abnormal PrP accumulation and clinical progression are highly accelerated in Drosophila compared with the rates of these processes in rodents or humans, the P101L mutant may be used for future genetic and pharmacologic studies as a novel invertebrate model of GSS.
Key words: prion; Drosophila; GerstmannSträusslerScheinker syndrome; PrP; neurodegeneration; misfolding
Received April 6, 2006;
revised Sept. 22, 2006;
accepted Oct. 20, 2006.
Correspondence should be addressed to either of the following: Surachai Supattapone, Department of Biochemistry, Dartmouth Medical School, 7200 Vail Building, Hanover, NH 03755, Email: supattapone{at}Dartmouth.edu; or Patrick J. Dolph, Department of Biology, Dartmouth College, Hanover, NH 03755, Email: partick.j.dolph{at}dartmoth.edu
Related articles in J. Neurosci.:
- Mad Fly Disease
- Jayanth Chandran and Patrick Lewis
J. Neurosci. 2007 27: 971-972.
[Full Text]
This article has been cited by other articles:

|
 |

|
 |
 
R. P. Rao, C. Yuan, J. C. Allegood, S. S. Rawat, M. B. Edwards, X. Wang, A. H. Merrill Jr., U. Acharya, and J. K. Acharya
Ceramide transfer protein function is essential for normal oxidative stress response and lifespan
PNAS,
July 3, 2007;
104(27):
11364 - 11369.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Chandran and P. Lewis
Mad Fly Disease
J. Neurosci.,
January 31, 2007;
27(5):
971 - 972.
[Full Text]
[PDF]
|
 |
|